OOIR: Observatory of International Research

Papers

(The H4-Index of Cancer & Metabolism is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Aspirin reprogrammes colorectal cancer cell metabolism and sensitises to glutaminase inhibition	75
The classification of obesity based on metabolic status redefines the readmission of non-Hodgkin’s lymphoma—an observational study	54
FOXO3a/miR-4259-driven LDHA expression as a key mechanism of gemcitabine sensitivity in pancreatic ductal adenocarcinoma	38
GCN2-SLC7A11 axis coordinates autophagy, cell cycle and apoptosis and regulates cell growth in retinoblastoma upon arginine deprivation	33
A role of arginase-1-expressing myeloid cells in cachexia	33
Metabolic convergence on lipogenesis in RAS, BCR-ABL, and MYC-driven lymphoid malignancies	32
Ketomimetic nutrients remodel the glycocalyx and trigger a metabolic defense in breast cancer cells	32
Cone photoreceptor phosphodiesterase PDE6H inhibition regulates cancer cell growth and metabolism, replicating the dark retina response	27
Lactate dehydrogenase A-coupled NAD+ regeneration is critical for acute myeloid leukemia cell survival	27
Autofluorescence imaging of endogenous metabolic cofactors in response to cytokine stimulation of classically activated macrophages	24
ACSL3 regulates lipid droplet biogenesis and ferroptosis sensitivity in clear cell renal cell carcinoma	24
Correction: Cholesterol reprograms glucose and lipid metabolism to promote proliferation in colon cancer cells	22
Circulating metabolome landscape in Lynch syndrome	21
Steatohepatitis-induced vascular niche alterations promote melanoma metastasis	21
Magnetospirillum magneticum triggers apoptotic pathways in human breast cancer cells	21
Glycemic status, insulin resistance, and mortality from lung cancer among individuals with and without diabetes	20
Identification and impact of microbiota-derived metabolites in ascites of ovarian and gastrointestinal cancer	19
Dexmedetomidine promotes colorectal cancer progression mediated by gamma-aminobutyric acid signaling	19
ATM inhibition blocks glucose metabolism and amplifies the sensitivity of resistant lung cancer cell lines to oncogene driver inhibitors	18